ANDA 205513, held by Strides Pharma. Carisoprodol.
As of Nov 16, 2026, ANDA 205513 (Carisoprodol), held by Strides Pharma, was first approved by FDA on Nov 12, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 12, 2015 | Original application | Approved | None posted |
| Carisoprodol250MG · tablet;oral | Carisoprodol | Discontinued |
| Carisoprodol350MG · tablet;oral | Carisoprodol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters